Pahl HL - Search Results

1

Sentinel mutations: the roses in the vineyard.

Pahl HL. Pahl HL. Blood. 2021 Nov 25;138(21):2019-2020. doi: 10.1182/blood.2021012345. Blood. 2021. PMID: 34821937 Free article. No abstract available.

2

The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.

Goerttler PS, Steimle C, März E, Johansson PL, Andreasson B, Griesshammer M, Gisslinger H, Heimpel H, Pahl HL. Goerttler PS, et al. Among authors: pahl hl. Blood. 2005 Oct 15;106(8):2862-4. doi: 10.1182/blood-2005-04-1515. Epub 2005 Jun 28. Blood. 2005. PMID: 15985544 Free article.

3

A JAK-in-the-cell cycle.

Pahl HL. Pahl HL. Blood. 2012 Feb 2;119(5):1096-7. doi: 10.1182/blood-2011-11-393462. Blood. 2012. PMID: 22308276 Free article.

4

Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia.

Aumann K, Frey AV, May AM, Hauschke D, Kreutz C, Marx JP, Timmer J, Werner M, Pahl HL. Aumann K, et al. Among authors: pahl hl. Blood. 2013 Jul 4;122(1):93-9. doi: 10.1182/blood-2012-11-463257. Epub 2013 May 13. Blood. 2013. PMID: 23670178 Free PMC article.

5

Many roads lead to MPN.

Pahl HL. Pahl HL. Blood. 2014 Apr 3;123(14):2133-4. doi: 10.1182/blood-2014-02-554709. Blood. 2014. PMID: 24700715 Free PMC article.

6

Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms.

Peeken JC, Jutzi JS, Wehrle J, Koellerer C, Staehle HF, Becker H, Schoenwandt E, Seeger TS, Schanne DH, Gothwal M, Ott CJ, Gründer A, Pahl HL. Peeken JC, et al. Among authors: pahl hl. Blood. 2018 May 3;131(18):2065-2073. doi: 10.1182/blood-2017-10-810622. Epub 2018 Mar 8. Blood. 2018. PMID: 29519804 Free PMC article.

7

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.

Jutzi JS, Basu T, Pellmann M, Kaiser S, Steinemann D, Sanders MA, Hinai ASA, Zeilemaker A, Bojtine Kovacs S, Koellerer C, Ostendorp J, Aumann K, Wang W, Raffoux E, Cassinat B, Bullinger L, Schlegelberger B, Valk PJM, Pahl HL. Jutzi JS, et al. Among authors: pahl hl. Blood. 2019 Apr 18;133(16):1766-1777. doi: 10.1182/blood-2018-09-875047. Epub 2019 Feb 12. Blood. 2019. PMID: 30755419 Free PMC article.

8

Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera.

Temerinac S, Klippel S, Strunck E, Röder S, Lübbert M, Lange W, Azemar M, Meinhardt G, Schaefer HE, Pahl HL. Temerinac S, et al. Among authors: pahl hl. Blood. 2000 Apr 15;95(8):2569-76. Blood. 2000. PMID: 10753836 Free article.

9

Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera.

Klippel S, Strunck E, Busse CE, Behringer D, Pahl HL. Klippel S, et al. Among authors: pahl hl. Blood. 2002 Oct 1;100(7):2441-8. doi: 10.1182/blood-2002-03-0949. Blood. 2002. PMID: 12239154 Free article.

10

Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis.

Klippel S, Strunck E, Temerinac S, Bench AJ, Meinhardt G, Mohr U, Leichtle R, Green AR, Griesshammer M, Heimpel H, Pahl HL. Klippel S, et al. Among authors: pahl hl. Blood. 2003 Nov 15;102(10):3569-74. doi: 10.1182/blood-2003-03-0919. Epub 2003 Jul 31. Blood. 2003. PMID: 12893745 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page